Brain

Parkinson's & Movement disorders

Researchers stimulate improvements in Parkinson's treatment

New research led by QIMR Berghofer Medical Research Institute has identified ways to make the most widely-used advanced treatment for Parkinson's disease—deep brain stimulation therapy—more effective and safer.

Neuroscience

Alternative strategy for stalling Alzheimer's neurodegeneration

Boosting levels of the neurotransmitter norepinephrine with atomoxetine, a repurposed ADHD medication, may be able to stall neurodegeneration in people with early signs of Alzheimer's disease, a study conducted at Emory Brain ...

Neuroscience

'Time is vision' after a stroke

A person who has a stroke that causes vision loss is often told there is nothing she can do to improve or regain the vision she has lost. New research from the University of Rochester, published in the journal Brain, may ...

Neuroscience

An antibody-based drug for multiple sclerosis

Inserm Unit U919, directed by Prof. Denis Vivien ("Serine Proteases and Physiopathology of the Neurovascular Unit") has developed an antibody with potential therapeutic effects against multiple sclerosis. The study, directed ...

Neuroscience

Dementia protein changes discovered in terminal childhood disease

In a world-first, researchers at Newcastle University have found that the brains of infants who sadly passed away with an extremely rare genetic condition, Krabbe disease, have similar changes to those seen in two age-related ...

page 11 from 40